Information about Valve Selection

Valve Replacement Forums

Help Support Valve Replacement Forums:

This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.

Brookwood

Well-known member
Joined
May 7, 2008
Messages
48
Location
salt lake city, UT, USA
I found this at Cleveland Clinic's website. Hope it helps for new members.

http://my.clevelandclinic.org/heart/services/surgery/transcript_avr.aspx

by Dr. Bruce Lytle

Hello, I'm Dr. Bruce Lytle and during the 28 years that I've been a cardiac surgeon at the Cleveland Clinic, one of the most common issues that we've talked with patients about is what kind of operation to have when the aortic valve needs to be repaired or replaced. There are a lot of good operations for aortic valve replacement, but there is no operation that is perfect for every patient. There are a lot of choices and those choices can be confusing.

Basically, aortic valve operations fall into two main groups. One group is the replacement of the aortic valve with mechanical aortic valve prosthesis. The second group represents a series of operations usually involving tissue valves that are used to treat the aortic valve. The purpose of those operations is to avoid taking Coumadin.

Today, mechanical aortic valve prostheses function extremely well and are very long lived. The chief advantage of having a mechanical aortic valve replacement is that the intrinsic failure of that valve is at least over 25 to 30 years, which is the length of time we followed patients with these types of prostheses in place. Intrinsic valve failure is extremely uncommon. The disadvantage of having a mechanical aortic valve is that it is necessary to take [Coumadin]Warfarin, an anti -coagulant. An anti-coagulant is a drug that makes the blood take longer to clot. If someone does not take anticoagulants, there's a risk of blood clots forming on the heart valve. There are a number of disadvantages of taking Warfarin or Coumadin.

One of the disadvantages would include if someone has a medical condition like bleeding ulcers, frequent nose bleeds, or severe hypertension, which would pose a risk if they're taking anti-coagulants. A second problem is that it is necessary to take a drug every day and requires attention to the details of doing that. The third disadvantage revolves around life style changes. Warfarin makes the blood take longer to clot, so if someone taking the medication gets involved in major trauma, that can conceivably be a major problem.

If someone's lifestyle includes activities such as downhill skiing, dirt-bike racing, and playing amateur football, those activities carry with it a trauma risk to someone that is taking Warfarin. Another disadvantage of mechanical valves is that although the likelihood of needing another operation is low, it is not zero. By the time someone has a mechanical aortic valve in place for 20 years the likelihood that they would have had another operation is somewhere around 20%.

A series of other operations have developed that are designed to avoid the need to take Warfarin. Most of those operations involve replacement of the aortic valve with some type of tissue. These procedures include a heterograph, which is a cow valve or a pig valve; an aortic valve homograft, which is a human valve transplant; or an operation called the Ross operation or pulmonary auto-transplantation, where the pulmonic valve is used to replace the aortic valve and then the pulmonic valve is replaced with a homograft. All of these operations have advantages and disadvantages.

The most common tissue valve-type operation is replacement of the aortic valve with either a pig valve or a cow valve. The advantage of that strategy is that it is a very standard operation that is carried out at extremely low risk, and it is not necessary to take Warfarin. The disadvantage of this and all other operations involving tissue valves is that they can eventually wear out. The likelihood of a heterograph wearing out is age related. The older someone is, the more slowly these valves wear out. So for someone over 65 years of age, the likelihood that they would need another operation 15 years after their first operation is about 15%.

An aortic valve homograft is a human valve transplant. It had been our hope since the late 1980's and early 1990's that aortic valve homografts would last longer than heterografts. Unfortunately, that has not turned out to be the case. They appear to wear out at about the same rate. The disadvantages of homografts are that the operation to put one in is a primary operation and is bigger than the operation to put in a heterograft. The re-operation for a homograft is also considerably more difficult than a re-operation for a heterograft. Now, fortunately, in experienced hands, we've found that the risk of doing those homograft re-operations has been relatively low, but they are bigger operations than the re-operation of a heterograft. Therefore we do not choose to use homografts, except in a couple of very specific circumstances. One is in the treatment of valve infections, where homografts represent a very good option and have a very low rate of re-infection. The second is to treat situations where the original valve that was put in appears to be a bit too small for the patient, since homografts are a very efficient valve and relieve the obstruction across small valves extremely effectively.

Another strategy that was developed actually quite a long time ago for replacing the aortic valve is called the Ross operation. This involves taking the pulmonic valve and transplanting it to the aortic valve and then replacing the pulmonic valve with a homograft. The reason that that was originally thought to have been a good idea, and why a lot of these operations have been preformed, was the hope to have [a] permanent aortic valve prosthesis, and then to do a bunch of re-operations for the pulmonic valve over time. Unfortunately, it has turned out that the total re-operation rate for the Ross operation has been somewhere in the neighborhood of 20-25% ten years after the operation, which is higher than the rate for heterografts. The situation where the Ross operation clearly has a real advantage is in children or young adults where the Ross replacement can grow with time. So, if it is important that the aortic valve prosthesis get bigger as the patient gets bigger, that is possible with the Ross operation. The use of the Ross operation is most effective for someone who is in their teens and even younger.

What this all adds up to is that there is no perfect operation. In general as patients get older we tend to use many more biologic prosthesis-usually heterografts. As we get older the risks of taking Coumadin become greater and the likelihood of valve failure become less. With someone who is younger, we tend to have the option of having a mechanical valve just because it can give us better longevity. However, the patient’s preference is extremely important in this area and we use a lot of biologic valves for patients in their 30's and 40's who wish to remain active and not to change their lifestyle.

Fortunately, the risk of a re-operation for a heterograft, particularly a first re-operation, has been extremely low in experienced hands so we're not reluctant to do that. It is very important to remember that the patient’s preference plays a tremendous role in the choice of operation, because there is no operation that has distinguished itself as superior for everybody. When contemplating having an aortic valve replacement, it is important to have a detailed talk with your surgeon about the choices involved and depict the situation that is most likely to be the best for you.
 
Good post!

A couple things for me to comment on.

1. If you have major trauma, you have major problems Coumadin or not. It's their job stop the bleeding.
2.He fails to mention that the medical profession itself has not stayed up with recent advancements in anticoagulation. By experience, the medical profession is far more apt to make mistakes (mismanagement) then the patients taking the anticoagulant. Instead of putting the burden and blame on both, the medical profession and the patient, he mentions only the patient. We see that every single day in the Anticoagulation forum.
3. The lifestyle thing-With everything you do there is a risk. That is no reason to stop doing the things you love. Use common sense, use protections as required and enjoy life.

I didn't think the failure rate of the Ross procedure was that high. I know a few that have failed almost from the get go, but didn't think the overall rate was that high.
 
Thanks Ross3. That's a surprising new report for us here and seems to say things differently than we've seen here lately posted by others.

I was going to make the same comments as Ross (original :D) made. So "ditto" for me.
 
Good post!

A couple things for me to comment on.

1. If you have major trauma, you have major problems Coumadin or not. They can stop the bleeding.
2.He fails to mention that the medical profession itself has not stayed up with recent advancements in anticoagulation. By experience, the medical profession is far more apt to make mistakes (mismanagement) then the patients taking the anticoagulant. Instead of putting the burden and blame on both, the medical profession and the patient, he mentions only the patient. We see that every single day in the Anticoagulation forum.
3. The lifestyle thing-With everything you do there is a risk. That is no reason to stop doing the things you love. Use common sense, use protections as required and enjoy life.

I didn't think the failure rate of the Ross procedure was that high. I know a few that have failed almost from the get go, but didn't think the overall rate was that high.

That's because it's not Ross. The latest stats I've read is that 80% of autografts and 75% of homograft pulmonary valves have a freedom of re-operation at 20 years. And this includes the data before they improved the procedure to include grafting the root along with the pulmonary valve on the autograft and using a pulmonary homograft instead of an aortic homograft to replace the pulmonary valve. Including the root on the autograft has reduced the amount of reops due to root dilation and/or aneurysms. Using a pulmonary homograft instead of an aortic homograft (which was more readily available than pulmonary homografts back when aortic homografts were used more to replace aortic valves) has reduced the early failure of the replacement in the pulmonary position significantly.

Another strategy that was developed actually quite a long time ago for replacing the aortic valve is called the Ross operation. This involves taking the pulmonic valve and transplanting it to the aortic valve and then replacing the pulmonic valve with a homograft. The reason that that was originally thought to have been a good idea, and why a lot of these operations have been preformed, was the hope to have [a] permanent aortic valve prosthesis, and then to do a bunch of re-operations for the pulmonic valve over time. Unfortunately, it has turned out that the total re-operation rate for the Ross operation has been somewhere in the neighborhood of 20-25% ten years after the operation, which is higher than the rate for heterografts. The situation where the Ross operation clearly has a real advantage is in children or young adults where the Ross replacement can grow with time. So, if it is important that the aortic valve prosthesis get bigger as the patient gets bigger, that is possible with the Ross operation. The use of the Ross operation is most effective for someone who is in their teens and even younger.

Sorry but I had to add his statements about the Ross...if no other reason than to point out how misleading...no...dumb...his statements are. I would say that someone like me...who was 43 when I had the RP performed...would in all likelihood need my pulmonary valve replaced no more than one time. I'm certainly hoping that I won't need "a bunch of re-operations for the pulmonic valve over time". If I knew that I would have never selected the RP. :D
 
Bryan I'm not questioning you, but could you please post a link to the resource you have for your study? It would be helpful to all I believe.
 
Bryan, I don't think Dr Lyttle was implying that every individual who had a RP would need a whole bunch of reoperations - rather I took it to mean that a whole bunch of operations were performed, therefore there would likely be a whole bunch of re-ops across the group...if you get my drift.

And, 80% success rate is the same as saying 20% failure rate, isn't it? It's just another way of stating the same equation :confused:

But anyway I hope you are well and I am glad that you were able to get the valve replacement of your choice.

Bridgette
 

The results are from valves implanted between 1991 and 2000. There is a whole new generation of nonmechanicals available in 2008.
 
One of the reasons I found Ross3's article interesting is that it was from Mayo - reporting that 50 - 70 year olds did better with mechanicals than with tissue. For a while here, I've observed that people who go to Cleveland Clinic have a greater chance of receiving a tissue valve and people who go to Mayo have a greater chance of receiving a mechanical. I found myself wondering how Cleveland would interpret the same data - or if they would have different data to offer. I just find it interesting that 2 of the major institutions have such differing opinions, in general terms.

Don't forget that there are new generations of mechanicals now too than there were 1991 - 2000. So it would be interesting to see a new side by side study. But the very nature of valve advancements and reports is that the newest valves don't have the time line to accurately report outcomes. So I guess it stands to reason that studies (even for 2008 as in the Mayo study) would need to use valves that have been in use a while.
 
Bryan I'm not questioning you, but could you please post a link to the resource you have for your study? It would be helpful to all I believe.

Ross,

The stats I mentioned were gathered by a variety of sites because I couldn't seem to "get my google on" and find them all on one site. I tried a different combination of words tonight and I came across the site I had found before I had made my decision to go with the RP. A word of warning...the reference has not been updated since 1999, but I believe that if anything the stats have become better since the introduction of improved surgical techniques.

7. Long Term Results
This information primarily comes from the Heart Surgery Forum.

7.1. Overall Results
The first Ross Procedure (pulmonary autotransplant) was performed in 1967. However, the current surgical techniques were not refined until at least 1976. Since that time, the results have improved dramatically. Postoperative patient survival at 20 years is an impressive 80% overall. Of those, 85% had not required reoperation, and 75% were free from any other event, including endocarditis.
[1],[2]

7.2. Reoperation Rates
Ross and colleagues followed 339 patients for up to 24 years following surgery. Only 15% of surviving patients required any additional valve procedures and most of these were for replacement of the homograft valve used to replace the patients pulmonary valve, not the aortic substitute. Fortunately, it is easier to replace the right ventricular substitute (the pulmonary valve). Follow-up of recent Ross cases where a human pulmonary artery homograft was initially used to reconstruct the right ventricular outflow tract has shown a remarkable freedom from failure (94% at 5 years, 83% at 20 years). Although pioneered solely by Mr. Donald Ross of London, England, surgeons in many other centers throughout the world are able to reproduce similar excellent results with the Ross Procedure. Reoperation rates for failure of the autotransplant and/or the right ventricular homograft are neglible in most centers (less than 10% at 10 years).
There is growing evidence that a pulmonary autograft properly implanted into the aortic position will continue functioning indefinately. The tissues of the patients own pulmonary valve have not shown a tendency to calcify, degenerate, perforate, or develop leakage over time even when transplanted into the higher pressure aortic position. There have been a few reports of late occurring dilation of the aortic root causing central leakage of the autotransplanted valve. However, this problem occurred before the technique of total root replacement was widely adopted. It is now known that secondary root dilatation can be prevented by reinforcing the aortic diameter with a cuff of Dacron, Teflon, or native pericardium during implantation of the pulmonary autograft. Post-operative studies now confirm that leakage is present in only 10% of modern cases, and usually will not progress.

Dr. Ronald Elkins from Oklahoma City has reported about 15% of pulmonary homografts will contract or shrink within 6 months of implantation. However, this does not appear to make a major difference in function of the homograft. Also, now that a pulmonary homograft is seen as a much better replacement for the pulmonary valve, the overall results of the Ross procedure have improved. When the right ventricular reconstruction is done with a pulmonary homograft, the freedom from degeneration is 94% at 5 years and still an admirable 83% at 18 years[Ross 1996].

[1]

7.3. Ross Registry Data
The International Ross Registry includes data on over 2,000 Ross procedures performed by 126 surgeons throughout the world. The average age of the patient population at the time of surgery was 28.7 years. Seventy-three percent of the patients were males. Over half of these cases were operated for congenital aortic valve disease, such as bicuspid aortic stenosis. Over 30% of these patients had undergone heart surgery at some time before the Ross procedure was performed. The combined operative mortality rate for the over 2,000 patients in the Registry (including small babies) was 5.4%. However, in stable adult patients undergoing elective operations, the mortality rate is now below 1%[Ross 1991]. The incidence of post-operative bleeding requiring reoperation was an admirable 0.9%. The symptoms or findings of aortic valve disease were relieved or greatly improved in all patients. Follow-up echocardiograms revealed only trivial or mild valve leakage in the vast majority.
In the "classic" era of the Ross procedure (prior to 1986), there were some late failures. Of these, 73% initially had the pulmonary valve implanted using the subcoronary ("freehand") technique. Due to this higher rate of surgical failure, this technique has been abandoned by most surgeons. Only 16% of the failures occured in patients who had full root replacement with the entire sino-tubular mechanism of the pulmonary valve.

http://members.cox.net/myrossprocedure/RossFAQ.html#sect-7.1

It appears that I was somewhat conservative in my numbers, but with more surgeons (with less experience IMO) willing to perform the RP I think the numbers I gave are pretty close but possibly a bit on the low side.

------------------------------------------------------------------

Wow I'm on a roll...here are stats from Dr. Paul Stelzer's site.

The primary long term risk of the Ross Procedure is the need for further surgery. Fortunately, this has been required in less than 10% of patients up to 10 years. Data are not sufficient to calculate the risk out to 20 years, but it is anticipated that 80% of patients will be free from re-operation up to that point in time. The following data are from Dr. Stelzer's series of 421 patients. (It should be noted that the comprehensive collection of follow up data is currently in process and these numbers reflect only those patients of whom he has personal knowledge.)

Twenty-one patients have required re-operation for regurgitation of the (new) aortic valve. Four of these have been due to technical problems at the time of original surgery and two have been endocarditis. Two patients developed a degenerative disease of the leaflets and the whole pulmonary root. Nine patients developed dilatation of the new aortic root which caused the valve to leak. Four others had primary mitral regurgitation which required surgery and there was moderate aortic regurgitation that was not wise to leave alone. Of note, the two with endocarditis had both had active endocarditis at the time of first operation.
Only three patients have required surgery for the pulmonary homograft placed into the right ventricular outflow tract. One other had a balloon dilatation of the homograft. Four patients had further surgery for mitral regurgitation and two others needed coronary bypass grafting. All the repeat operations have been succesful.

I take those inital stats of 10% at ten years and projected 20% at twenty years as the combined risk of re-operation from both valves.

http://www.ps4ross.com/ross_procedure/risks/longterm.html

The way I look at it, on a lot of sites where first hand experiences is shared the percentage of people who report problems are higher that the percentage of people who don't have problems. I believe it was Karlynn that was using cars as an example in another thread. If you go to Edmunds.com you will find a huge discrepancy in the amount of negative posts about a car compared to the amount of positive posts...even if the car is highly rated by Edmunds. It's human nature to complain if something goes wrong more often than give accolades when things work out great. Come to think of it I've had some bosses like this...the only time I heard from them is when I screwed up. :D
 

Latest posts

Back
Top